CN103664947B - 一种碳青霉烯抗菌药物的晶型及其制备方法 - Google Patents
一种碳青霉烯抗菌药物的晶型及其制备方法 Download PDFInfo
- Publication number
- CN103664947B CN103664947B CN201210324344.9A CN201210324344A CN103664947B CN 103664947 B CN103664947 B CN 103664947B CN 201210324344 A CN201210324344 A CN 201210324344A CN 103664947 B CN103664947 B CN 103664947B
- Authority
- CN
- China
- Prior art keywords
- crystallization
- preparation
- crystal
- type
- peinan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 6
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 5
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title claims 2
- 239000013078 crystal Substances 0.000 title abstract description 37
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 230000015572 biosynthetic process Effects 0.000 title abstract description 14
- 238000002425 crystallisation Methods 0.000 claims abstract description 38
- 230000008025 crystallization Effects 0.000 claims abstract description 38
- 238000000634 powder X-ray diffraction Methods 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims description 3
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical compound CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 abstract description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 4
- 239000005864 Sulphur Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical compound OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 abstract description 3
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 14
- 238000005755 formation reaction Methods 0.000 description 12
- 238000000967 suction filtration Methods 0.000 description 12
- 238000003756 stirring Methods 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000002441 X-ray diffraction Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- -1 carbapenem compound Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000012065 filter cake Substances 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 230000006837 decompression Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 229910017488 Cu K Inorganic materials 0.000 description 3
- 229910017541 Cu-K Inorganic materials 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 201000001376 Familial Combined Hyperlipidemia Diseases 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 101150116596 dhp-1 gene Proteins 0.000 description 1
- AVAACINZEOAHHE-VFZPANTDSA-N doripenem Chemical compound C=1([C@H](C)[C@@H]2[C@H](C(N2C=1C(O)=O)=O)[C@H](O)C)S[C@@H]1CN[C@H](CNS(N)(=O)=O)C1 AVAACINZEOAHHE-VFZPANTDSA-N 0.000 description 1
- 229960000895 doripenem Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210324344.9A CN103664947B (zh) | 2012-09-05 | 2012-09-05 | 一种碳青霉烯抗菌药物的晶型及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210324344.9A CN103664947B (zh) | 2012-09-05 | 2012-09-05 | 一种碳青霉烯抗菌药物的晶型及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103664947A CN103664947A (zh) | 2014-03-26 |
CN103664947B true CN103664947B (zh) | 2015-11-25 |
Family
ID=50303813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210324344.9A Active CN103664947B (zh) | 2012-09-05 | 2012-09-05 | 一种碳青霉烯抗菌药物的晶型及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103664947B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106255694A (zh) | 2014-04-28 | 2016-12-21 | Jw制药公司 | 新型多尼培南晶体及其制备方法 |
CN106943353B (zh) * | 2016-01-06 | 2022-07-01 | 山东新时代药业有限公司 | 一种注射用多立培南及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101935321A (zh) * | 2010-07-20 | 2011-01-05 | 深圳市海滨制药有限公司 | 1β甲基碳青霉烯类抗生素的合成方法 |
EP2275424A1 (en) * | 2009-07-17 | 2011-01-19 | Sandoz AG | Doripenem crystallization process |
-
2012
- 2012-09-05 CN CN201210324344.9A patent/CN103664947B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2275424A1 (en) * | 2009-07-17 | 2011-01-19 | Sandoz AG | Doripenem crystallization process |
CN101935321A (zh) * | 2010-07-20 | 2011-01-05 | 深圳市海滨制药有限公司 | 1β甲基碳青霉烯类抗生素的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103664947A (zh) | 2014-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102363617B (zh) | 一种厄他培南单钠盐结晶体及其制备方法 | |
CN102558182B (zh) | 一种厄他培南钠晶型及其制备方法 | |
CN102924483B (zh) | 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物 | |
CN102838623B (zh) | 头孢米诺钠化合物晶体及其制备方法和含有该化合物晶体的无菌粉针 | |
CN103319502B (zh) | 一种磺苄西林钠的制备方法 | |
CN103664947B (zh) | 一种碳青霉烯抗菌药物的晶型及其制备方法 | |
CN108997154B (zh) | 具有低氯化钠含量和低吸湿性的甜菜碱制剂制备方法 | |
WO2017140072A1 (zh) | 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢呋辛钠新晶型化合物及制剂 | |
CN103601739A (zh) | 一种头孢西丁钠化合物及其制备方法 | |
CN103304582B (zh) | 一种头孢西丁钠的化合物、其制备方法及其药物组合物 | |
CN102731508A (zh) | 一种晶体形式的厄他培南中间体及其制备方法和应用 | |
CN102432611B (zh) | 一种双保护厄他培南结晶体及其制备方法 | |
CN102952165B (zh) | 一种从木糖母液中提取l-阿拉伯糖的方法 | |
CN104628743A (zh) | 头孢硫脒化合物的新晶型及其结晶制备方法 | |
CN110143973B (zh) | 一种氟氧头孢钠的制备工艺 | |
CN103025733B (zh) | 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途 | |
CN102617612B (zh) | 比阿培南b型结晶 | |
CN105294734B (zh) | 一种制备头孢尼西二苄基乙二胺盐的方法 | |
CN103664948B (zh) | 一种替比培南酯的中间体的结晶及其制备方法 | |
WO2017140073A1 (zh) | 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢硫脒新晶型化合物及制剂 | |
CN103588787A (zh) | 一种头孢米诺钠晶体及其制备方法与应用 | |
CN104788426B (zh) | 一种奥美拉唑钠半水合物及其制备方法 | |
WO2014094659A1 (zh) | 一种美罗培南三水合物晶体的制备方法 | |
CN103130820A (zh) | 一种头孢呋辛赖氨酸的合成方法 | |
CN110698478A (zh) | 一种厄他培南单钠盐的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160608 Address after: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 888 250101 Patentee after: Shandong Fu Ruida Pharmaceutical Group company Patentee after: Ling Peixue Address before: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Patentee before: Ling Peixue |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Crystal form of carbapenem antimicrobial medicament and preparation method of novel crystal form Effective date of registration: 20170425 Granted publication date: 20151125 Pledgee: Qi commercial bank Limited by Share Ltd small business financial services center Pledgor: Shandong Fu Ruida Pharmaceutical Group company Registration number: 2017370000046 |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 250101 888 Xinjie street, Ji'nan high tech Zone, Shandong Co-patentee after: Ling Peixue Patentee after: Shandong Freda Pharmaceutical Group Co., Ltd. Address before: 250101 888 Xinjie street, Ji'nan high tech Zone, Shandong Co-patentee before: Ling Peixue Patentee before: Shandong Fu Ruida Pharmaceutical Group company |